People

Tirtha Chakraborty
Tirtha Chakraborty is named Venture Partner in Droia’s current public directory. The published professional background includes Ph.D. in Molecular Biology from TIFR, Mumbai, India; Trained at Yale, NIH and Harvard in RNA metabolism, genetic engineering and immunology; mRNA platform lead, Moderna Therapeutics; Head of Hematology, CRISPR Therapeutics; VP of Cell Therapy, Sana Biotechnology; CSO and Head of Tech Ops, Vor Bio; SAB member at Specific Biologics. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.
Roles
Droia Ventures
CurrentVenture Partner